Key result
Ticagrelor exhibits pleiotropic and molecular differences versus clopidogrel that may influence post-MI efficacy.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fender et al. (2020) studied this question. Ticagrelor exhibits pleiotropic actions and molecular differences compared to clopidogrel that may influence its clinical efficacy following myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: